Peter Jeffrey Conn
Directeur/Membre du Conseil chez Appello Pharmaceuticals, Inc.
Profil
Peter Jeffrey Conn is the founder of Karuna Therapeutics, Inc. which was founded in 2009.
Currently, he holds a position as a Director at Appello Pharmaceuticals, Inc.
Postes actifs de Peter Jeffrey Conn
| Sociétés | Poste | Début |
|---|---|---|
Appello Pharmaceuticals, Inc.
 Appello Pharmaceuticals, Inc. BiotechnologyHealth Technology Appello Pharmaceuticals, Inc. operates as a preclinical-stage company focused on advancing novel positive allosteric modulators of mGlu4 for the treatment of Parkinson’s disease. The company is headquartered in Nashville, TN. | Directeur/Membre du Conseil | - |
Anciens postes connus de Peter Jeffrey Conn
| Sociétés | Poste | Fin |
|---|---|---|
| KARA THER | Fondateur | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Karuna Therapeutics, Inc.
 Karuna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Karuna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. engages in business of research and development of therapies utilizing muscarinic cholinergic receptors to treat psychosis and cognitive impairment in numerous central nervous system disorders. The company was founded by Andrew Miller, Eric Elenko, and Peter Jeffrey Conn in July 2009 and is headquartered in Boston, MA. | Health Technology |
Appello Pharmaceuticals, Inc.
Appello Pharmaceuticals, Inc. BiotechnologyHealth Technology Appello Pharmaceuticals, Inc. operates as a preclinical-stage company focused on advancing novel positive allosteric modulators of mGlu4 for the treatment of Parkinson’s disease. The company is headquartered in Nashville, TN. | Health Technology |
